Drug Trial Radar · NCT00286208
Study of Sublingual Versus Oral Misoprostol Administration Following Mifepristone 200 mg for Abortion up to 63 Days Gestation
Last checked: Nov 20, 2026Latest source record: Feb 19, 2014 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
1,443
Actual
Start
Aug 2005
Primary completion
Jan 2008
Study completion Jan 2008
Sponsor
- Lead sponsor
- Gynuity Health ProjectsAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Feb 3, 2006
Design
- Study type
- Interventional
- Phase
- Not applicable
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- Who can join
- Female only
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
This open-label, randomized study is being conducted to determine whether a dose of 400 mcg of sublingual misoprostol (i.e., under the tongue) taken 24 hours following administration of mifepristone 200 mg is effective and acceptable at inducing an abortion compared with misoprostol taken orally. The goal of this study is to provide answers to the following four questions: 1. Is a regimen of medical abortion with mifepristone using sublingual misoprostol at least as effective as using oral misoprostol up to 63 days since the last menstrual period (LMP)? 2. Are the side effects with sublingual use tolerable for women? 3. Is sublingual administration of misoprostol acceptable to women? 4. Is one of the regimens (sublingual or oral) superior in terms of efficacy, safety (side-effects) or acceptability?
Conditions
- Induced Abortion
Interventions
Mifepristone, misoprostolDrug
Primary outcomes
What the sponsor says the trial is designed to measure.
- Need for surgical completion for incomplete abortions or ongoing viable pregnancies at follow up visit Study day 15.Time frame: 2 weeks after mifepristone administration
Locations
9 sites in 3 countries. Site status is shown where the registry gives one.
State University of Medicine and Pharmacy
Chisinau, Moldova
Centre de Planification Familiale de l'Ariana
Aryanah, Tunisia
Centre de Planification Familiale la Bardo
Tunis, Tunisia
Maternité de La Rabta
Tunis, Tunisia
Private clinic
Tunis, Tunisia
Dr. Zekai Tahir Burak Women's Health Training and Research Hospital
Ankara, Turkey (Türkiye)
MoH Ankara Etlik Maternity and Gyneacological Training Hospital
Ankara, Turkey (Türkiye)
Haydarpaşa Numune Training and Research Hospital Family Planning Clinic
Istanbul, Turkey (Türkiye)
Ege Maternity and Gyneacological Training and Research Hospital
Izmir, Turkey (Türkiye)
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.